View Article

Abstract

Clinical evidence supports the efficacy of a combined formulation of Carisoprodol, Paracetamol, and Caffeine in symptom reduction. This study describes the development of a stability-indicating RP-HPLC method for the accurate quantification of CAR, PCM, and CAF within their tablet dosage form. The chromatographic separation was achieved on a HIBAR C18 column (250 x 4.6 mm, 5 µm) at ambient temperature using an isocratic elution mode. The optimized mobile phase consisted of Methanol: 0.025 M Potassium Dihydrogen Phosphate Buffer [40:60 v/v], delivered at a flow rate of 0.8 mL/min, with UV detection at 210 nm. Crucially, the optimized method effectively separated CAR, PCM, and CAF from degradation products generated under various forced degradation conditions, highlighting its stability-indicating capability. Validated in accordance with ICH guidelines, the method demonstrated linearity over the concentration ranges of 8.75-43.75 µg/mL for CAR, 16.25-81.25 µg/mL for PCM, and 1.6-8 µg/mL for CAF. The determined LOD and LOQ values were 0.246 µg/mL and 0.746 µg/mL for CAR, 0.501 µg/mL and 1.521 µg/mL for PCM, and 0.064 µg/mL and 0.196 µg/mL for CAF, respectively. Accuracy of the method was established, yielding ranges of 98.10-101.98% for CAR, 99.08-101.54% for PCM, and 98.13-101.88% for CAF. Subsequent application of the developed and validated method revealed the % purity of CAR, PCM, and CAF to be 100.38%, 100.10%, and 100.83%, respectively.

Keywords

Carisoprodol (CAR), Paracetamol (PCM), Caffeine (CAF), Reverse Phase High Performance Liquid Chromatography (RP-HPLC), Forced degradation studies, Analytical Method Validation.

Introduction

Carisoprodol (CAR) is a muscle relaxant that target the brain and spinal cord. It’s thought to reduce muscle spasms by inhibiting the multi-synaptic reflex, likely through its suppressive effect on inter-neuronal activity. This compound is officially listed in the IP, BP and USP. [1-3] (Figure 1[A]). Paracetamol is a widely used as analgesic and antipyretic agent, primarily through its inhibitory effect on prostaglandin synthesis within the brain. This action subsequently mitigates the release of chemical mediators that induce pain and elevate body temperature. This compound is officially listed in the IP, BP and USP. [4,5] (Figure 1[B]). Caffeine enhances the effectiveness of paracetamol. This attributed to caffeine’s ability to cross blood brain barrier and block adenosine receptor. Since adenosine play a crucial role in energy transfer and promoting sleep, its blockade by caffeine contributes to the potentiated analgesic effect. Caffeine is official in IP, BP and USP [6-8] (Figure 1[C]).

(A)

(B)

(C)

Figure 1: (A)Carisoprodol, (B)Paracetamol and (C)Caffeine

Carisoprodol, Caffeine and Paracetamol act synergistically to alleviate pain and muscle spasms. Consequently, the quantitative analysis of CAR, PCM and CAF in both isolated forms and combined with other therapeutic agents, has been a subject of numerous reported analytical method [9-25], despite extensive literature, a significant remains as no stability indicating HPLC method is currently available for the accurate quantification of carisoprodol, paracetamol and caffeine in their combined dosage form.

MATERIALS AND METHODS

Instrumentation and reagents

For the analytical procedure, a Shimadzu HPLC (LC 2010), featuring an Ultraviolet-visible detector and binary gradient system, was employed. LC Solution software facilitated data collection and processing. Separation occurred on a HIBAR ODS C18 column (250 mm × 4.6 mm, 5 µm). Yarrow chem Pvt. Ltd. and RMS scientific services provided API, chemical and reagents, all used in mobile phase preparation. A Mettler Toledo weighing scale (0.1 mg sensitivity) ensured precise material measurements, and a Labman LMPH-9 pH meter was used for pH adjustments.

Preparation of Standard Solution:

A precisely weighed mixture of CAR, PCM, and CAF (175 mg, 325 mg, and 32 mg respectively) was dissolved in methanol in a 100 mL volumetric flask, yielding a stock solution of 1750 µg/mL CAR, 3250 µg/mL PCM, and 320 µg/mL CAF. Subsequent dilutions were performed: 1 mL of the stock solution was diluted to 10 mL with methanol to achieve concentrations of 175 µg/mL CAR, 325 µg/mL PCM, and 32 µg/mL CAF. A further 1 mL from this intermediate solution was then diluted to 10 mL with methanol, resulting in final concentrations of 17.5 µg/mL CAR, 32.5 µg/mL PCM, and 3.2 µg/mL CAF.

Selection of Detection Wavelength:

The UV spectra of working standards for CAR (10 µg/mL), PCM (6 µg/mL), and CAF (6 µg/mL) were recorded across the 200-400 nm region. Upon overlapping these spectra, an iso-absorptive point was identified at 210 nm. This specific wavelength was then chosen as the analytical wavelength for the development of the RP-HPLC method for the estimation of CAR, PCM, and CAF.

Optimization of separation conditions:

Several elution conditions were tried in order to get optimum separation. Detection wavelength was kept constant at 210 nm, while flow rate, organic phase and buffer proportions were varied. The condition that gave perfect separation, along with system suitability parameters, is highlighted as table 1.

Table 1: Optimized chromatographic conditions

Stationary Phase

HIBAR C18 (250*4.6 mm, 5µm)

Mobile Phase [v/v]

Methanol: Buffer [40:60 v/v]

Flow rate [ml/min]

0.8 ml/min

Detection Wavelength [nm]

210 nm

Temperature

Ambient

Injection Volume [microlitre]

20 microlitre

Run time [minute]

15 minutes

Retention Time [minute]

CAR:4.114 min, PCM:5.458 min, CAF:9.415 min

Figure 2: Optimized chromatogram of PCM+CAR+CAF (32.5+17.5+3.2 µg/ml)

RESULTS AND DISCUSSION

System Suitability:

All system suitability parameters, including retention time (Rt), tailing factor (T), resolution (Rs), and number of theoretical plates, were found to be within acceptable limits. This was confirmed after injecting a CAR+PCM+CAF (17.5+32.5+3.2 µg/mL) solution three times, and statistically evaluating the parameters presented in Table 2 against their prescribed ranges.

Table 2: System suitability parameters for CAR, PCM and CAF

Parameter

CAR

RSD

PCM

RSD

CAF

RSD

Retention time

4.02± 0.07

1.85

5.39±0.084

1.56

9.55 ± 0.13

1.40

Tailing Factor

1.15 ± 0.01

1.32

1.45 ± 0.02

1.38

1.36 ± 0.01

1.13

No. of theoretical plates

7864.66±109.25

1.39

5678.33±64.002

1.13

3401.33±54.19

1.59

Resolution

MEAN ± SD

RSD

Resolution 1

3.69±0.05

1.49

Resolution 2

7.29±0.09

1.24

               

Forced Degradation studies:

A forced degradation study was performed to assess the impact of degradation products under various stress conditions, including acidic, basic, oxidative, and dry heat environments. For this purpose, an initial stock solution was prepared: an accurately weighed equivalent of 175 mg Carisoprodol, 325 mg Paracetamol, and 32 mg Caffeine was dissolved in methanol in a 100 mL volumetric flask, achieving concentrations of 1750 µg/mL CAR, 3250 µg/mL PCM, and 320 µg/mL CAF. Following 10 minutes of sonication and filtration through Whatman filter paper, this stock solution was utilized for the comprehensive degradation experiments.

Acid Degradation

To assess acid degradation, 0.1 mL of Solution A was pipetted into a 10 mL volumetric flask, to which 5 mL of 1 N HCl was added. The solution was refluxed at 50°C for 60 minutes, then cooled to ambient temperature, neutralized with 1 N NaOH, and diluted to 10 mL with methanol, resulting in CAR+PCM+CAF (17.5+32.5+3.2 µg/mL). A 20 µL injection was performed, and the extent of degradation was determined by comparing the treated sample to a 0-hour control. A reagent blank (without stock solution) was also processed.

Figure 3: Chromatogram of Acid Hydrolysis [Blank]

Figure 4: Chromatogram of Acid Hydrolysis [Treated] [1N HCl, 50°C, 60 min]

Base Degradation

To assess base-induced degradation, 0.1 mL of Solution A was added to a 10 mL volumetric flask, followed by 5 mL of 1 N NaOH. This solution was refluxed at 50°C for 60 minutes. After cooling to ambient temperature, it was neutralized with 1 N HCl and diluted to 10 mL with methanol, yielding CAR+PCM+CAF (17.5+32.5+3.2 µg/mL). A 20 µL sample was injected onto the column, and the extent of degradation was determined by comparing the treated sample against a 0-hour control. A reagent blank (without stock solution) was also processed.

Figure 5: Chromatogram of Base Hydrolysis [Blank]

Figure 6: Chromatogram of Base Hydrolysis [Treated] [1N NaOH, 50°C, 60 min]

Oxidative Degradation

To assess oxidation-induced degradation, 0.1 mL of Solution A was pipetted into a 10 mL volumetric flask, followed by the addition of 5 mL of 3% v/v H?O?. The solution was heated at 50°C for 40 minutes. After cooling to ambient temperature, it was diluted to 10 mL with methanol, yielding CAR+PCM+CAF (17.5+32.5+3.2 µg/mL). A 20 µL sample was injected onto the column, and the extent of degradation was determined by comparing the treated sample against a 0-hour control. A reagent blank (without stock solution) was also processed.

Figure 7: Chromatogram of Oxidative Stress [Blank]

Figure 8: Chromatogram of Oxidative Stress [Treated] [3 % V/V H2O2, 50°C, 40 min]

Thermal Degradation

To assess dry heat degradation, a precise mixture of 175 mg Carisoprodol, 325 mg Paracetamol, and 32 mg Caffeine was spread in a petri dish and subjected to 70°C in a hot air oven for 2 hours. After this thermal exposure, the contents were quantitatively transferred to a 100 mL volumetric flask and diluted to volume with methanol, forming a stock solution of CAR+PCM+CAF (1750+3250+320 µg/mL). A 0.1 mL aliquot of this stock was then diluted to 10 mL with methanol to prepare the working solution at CAR+PCM+CAF (17.5+32.5+3.2 µg/mL).

Figure 9: Chromatogram of Thermal Stress [Treated] [70ºC for 2 hrs]

Table 3: Evaluation table of Forced Degradation Study

FD Condition

Area

CAR

PCM

CAF

% Degradation

of CAR

% Degradation

of PCM

% Degradation

of CAF

Acid hydrolysis

0 hr Area

6260334

2366430

970941

 

14.6 %

 

14 %

 

12.4 %

Treated area

5343887

2035801

850628

Base hydrolysis

0 hr Area

6247836

2387125

968956

 

18.3 %

 

15.2 %

 

13.7 %

Treated area

5104482

2024282

836209

Oxidative stress

0 hr Area

6310420

2347918

10011140

 

14.5 %

 

18.3 %

 

17.1 %

Treated area

5395409

1918249

8299235

Thermal stress

Standard Area

6459210

2454205

1031728

 

10.5 %

 

13.6 %

 

14.7%

Treated area

5780993

2130250

880064

Validation of Optimized method:

Linearity

Compliance with ICH Q2(R2) guidelines for linearity was confirmed for the developed HPLC method. Mean representative calibration curves (n=5) for CAR, PCM, and CAF displayed strong linearity, with regression coefficients consistently above 0.995. The established linear ranges were 8.75-43.75 µg/mL for CAR, 16.25-81.25 µg/mL for PCM, and 1.6-8 µg/mL for CAF. For visual reference, calibration curves are presented in (Figure 10) CAR, (Figure 11) PCM, and (Figure 12) CAF, and an overlay chromatogram demonstrating separation is available in (Figure 13).

Table 4: Linearity data for CAR

Sr no.

Concentration

[µg/mL]

Mean area ± SD

RSD

1

8.75

3247542 ± 49030.64

1.51

2

17.5

6459210.8 ± 91599.50

1.42

3

26.25

9331333.4 ± 121745.99

1.30

4

35

13069880.8 ± 150698.67

1.15

5

43.75

15828073 ± 146896.77

0.93

Linearity Regression Equation

y = 364015x + 26518

Regression Coefficient

0.999

Figure 10: Calibration curve for CAR (8.75-43.75 µg/mL)

Table 5: Linearity data for PCM

Sr no.

Concentration

[µg/mL]

Mean area ± SD

RSD

1

16.25

1416256.4 ± 18808.4

1.33

2

32.5

2454205 ± 30346.02

1.24

3

48.75

3489173 ± 40978.5

1.17

4

65

4675196 ± 49592.6

1.06

5

81.25

5841321 ± 53798.7

0.92

Linearity Regression Equation

y = 70362x + 120902

Regression Coefficient

0.998

Figure 11: Calibration curve for PCM (16.25-81.25 µg/mL)

Table 6: Linearity data for CAF

Sr no.

Concentration

[µg/mL]

Mean area ± SD

RSD

1

1.6

534798.2±8713.53

1.63

2

3.2

1031728±15793.89

1.53

3

4.8

1477353±20641.16

1.40

4

6.4

1898181±25238.86

1.33

5

8

2301259 ± 28766.06

1.25

Linearity Regression Equation

y = 286466x + 61358

Regression Coefficient

0.997

Figure 12: Calibration curve for CAF (1.6-8 µg/mL)

Figure 13: Overlay chromatogram for Linearity of CAR (8.75-43.75 µg/mL), PCM (16.25-81.25 µg/mL) and CAF (1.6-8 µg/mL)

Repeatability

Repeatability was evaluated by performing five replicate injections for each concentration of CAR, PCM, and CAF across the entire calibration range, ensuring short time intervals between injections. The peak areas generated for CAR, PCM, and CAF were then used to calculate the Relative Standard Deviation (RSD), providing an indication of method precision.

Table 7: Repeatability data of CAR

CAR

Concentration

µg/mL

8.75

17.5

26.25

35

43.75

AREA 1

3243566

6446003

9435660

13064253

15762877

AREA 2

3180060

6310334

9469654

12900212

15763568

AREA 3

3318559

6509910

9210652

13264789

15961872

AREA 4

3248962

6479908

9330641

12950897

15999219

AREA 5

3246565

6549899

9210060

13169253

15652830

mean

3247542

6459210.8

9331333.4

13069880.8

15828073

SD

49030.6

91599.5

121745.9

150698.6

146896.7

RSD

1.51

1.42

1.30

1.15

0.93

n= 5 determinations

Table 8: Repeatability data of PCM

PCM

Concentration

µg/mL

16.25

32.5

48.75

65

81.25

AREA 1

1416394

2467730

3520350

4706745

5869123

AREA 2

1394395

2467847

3515338

4690120

5769121

AREA 3

1439900

2467959

3419042

4730022

5799119

AREA 4

1401581

2467568

3490079

4609005

5890127

AREA 5

1429012

2399921

3501054

4640089

5879115

mean

1416256.4

2454205

3489173

4675196

5841321

SD

18808.4

30346.02

40978.5

49592.6

53798.73

RSD

1.33

1.24

1.17

1.06

0.92

n= 5 determinations

Table 9: Repeatability data of CAF

CAF

Concentration

µg/mL

1.6

3.2

4.8

6.4

8

AREA 1

546742

1027458

1484896

1896412

2336745

AREA 2

525759

1026932

1500087

1897398

2256456

AREA 3

526724

1017941

1489990

1880652

2306415

AREA 4

538010

1027258

1450896

1940123

2301322

AREA 5

536756

1059050

1460896

1876321

2305357

mean

534798.2

1031728

1477353

1898181

2301259

SD

8713.5

15793.8

20641.1

25238.8

28766.06

RSD

1.63

1.53

1.40

1.33

1.25

n= 5 determinations

Limit of detection and quantitation

Determination of the Limit of Detection (LOD) and Limit of Quantitation (LOQ) was achieved primarily through statistical calculation and visual detection techniques. Leveraging the linearity data, LOD and LOQ were statistically computed using the mean of the slope (S) and the standard deviation of the standard error (σ).

Table 10:  LOD and LOQ data for CAR, PCM and CAF

API

LOD

LOQ

By Statistical calculation

By Statistical calculation

Carisoprodol

0.246 µg/ml

0.746 µg/ml

Paracetamol

0.501 µg/ml

1.521 µg/ml

Caffeine

0.064 µg/ml

0.196 µg/ml

Intraday and Inter-day Precision

To establish method precision, both intra-day and inter-day precision were investigated. Samples containing CAR, PCM, and CAF at concentrations spanning the calibration range (8.75+16.25+1.6, 26.25+48.75+4.8, and 43.75+81.25+8 µg/mL) were prepared. Intra-day precision involved analyzing these mixtures multiple times on the same day, at different intervals, while inter-day precision required analyses on separate days. For each level, three determinations (n=3) were performed in both studies.

Table 11: Intraday and inter-day precision data of CAR

Concentration

(µg/ml)

Intraday

Mean± SD

RSD

Inter-day

Mean± SD

RSD

 

8.75

3272360±49890.86

1.52

3250220±47347.98

1.46

26.25

9508036.3±122951.19

1.29

9399653±115298.36

1.23

43.75

15826218±145708.47

0.92

15709532±137973.11

0.88

Table 12: Intraday and inter-day precision data of PCM

Concentration

(µg/ml)

Intraday

Mean± SD

RSD

Inter-day

Mean± SD

RSD

 

16.25

1426952.67±18864.36

1.32

1408057.67±18009.84

1.28

48.75

3544685.66±41281.59

1.16

3539348±39125.45

1.11

81.25

5859790±55590.77

0.95

5856131±50758.17

0.87

Table 13: Intraday and inter-day precision data of CAF

Concentration

(µg/ml)

Intraday

Mean± SD

RSD

Inter-day

Mean± SD

RSD

 

1.6

551475.3±8900.1

1.61

551075.3±8386.4

1.52

4.8

1501563±20816.6

1.39

1478727±19877.9

1.34

8

2342745±29461.8

1.26

2326178.3±27421.9

1.18

Accuracy

The accuracy of the analytical method was assessed through a standard addition (spiking) technique. Samples were fortified with known amounts of standard analytes at 50%, 100%, and 150% of the target concentration. Three determinations were performed at each spiking level.

Table 14: Accuracy data of CAR

Level of spiking

Amount of drug added (µg/ml)

Amount of drug recovered(µg/ml)

% Recovery

% Mean recovery ± SD

50 %

8.75

8.9

101.71

99.81 ± 1.75

8.75

8.6

98.29

8.75

8.7

99.43

100 %

17.5

17.67

100.97

100.13 ± 1.35

17.5

17.65

100.86

17.5

17.25

98.57

150 %

26.25

25.75

98.10

99.71 ± 2.03

26.25

26

99.05

26.25

26.77

101.98

Table 15: Accuracy data of PCM

Level of spiking

Amount of drug added (µg/ml)

Amount of drug recovered(µg/ml)

% Recovery

% Mean recovery ± SD

50 %

16.25

16.1

99.8

99.90 ± 0.94

16.25

16.4

100.92

16.25

16.2

99.69

100 %

32.5

33

101.54

100.82 ± 0.64

32.5

32.6

100.31

32.5

32.7

100.62

150 %

48.75

48.7

99.90

99.97 ± 0.52

48.75

48.5

99.49

48.75

49

100.51

Table 16: Accuracy data of CAF

Level of spiking

Amount of drug added (µg/ml)

Amount of drug recovered(µg/ml)

% Recovery

% Mean recovery ± SD

50 %

1.6

1.59

99.38

99.79 ± 1.91

1.6

1.63

101.88

1.6

1.57

98.13

100 %

3.2

3.25

101.56

100.52 ± 1.54

3.2

3.16

98.75

3.2

3.24

101.25

150 %

4.8

4.75

98.96

99.86 ± 1.07

4.8

4.85

101.04

4.8

4.78

99.58

Robustness

Robustness was determined by incrementally changing key method parameters and comparing the results to a standard preparation to observe any significant effects. For this study, the mobile phase flow rate and mobile phase composition were specifically varied.

Table 17: Robustness data of CAR+PCM+CAF by RP-HPLC method

Drug

CAR

PCM

CAF

Mobile phase composition

42-58

40-60

38-62

42-58

40-60

38-62

42-58

40-60

38-62

Effect on assay volume

Mean±SD

RSD

Mean±SD

RSD

Mean±SD

RSD

6402340±

94919.66

1.48

2495072±

25954.69

1.04

1012973±

12803.42

1.26

Flow rate

0.6

0.8

1

0.6

0.8

1

0.6

0.8

1

Effect on assay volume

Mean±SD

RSD

Mean±SD

 

RSD

Mean±SD

RSD

6418251±

87689.42

1.37

2379114±

27712.64

1.16

1045287±

17340.75

1.66

                         
Assay

The assay sample was prepared by calculating the average weight of 10 tablets. A quantity of tablet powder equivalent to 655.45 mg (175 mg CAR + 325 mg PCM + 32 mg CAF) was transferred to a 100 mL volumetric flask, and the volume was made up with methanol, resulting in a 1750+3250+320 µg/mL stock solution. After 10 minutes of sonication and filtration through a 0.45 µm Whatman filter paper, 0.1 mL of this filtrate was diluted to 10 mL with methanol, preparing the working sample solution of 17.5+32.5+3.2 µg/mL CAR+PCM+CAF. Three 20 µL injections of this solution were then made onto the column under optimized chromatographic conditions.

Table 18: Determination of CAR.PCM and CAF from its marketed formulation

Drug

Amount taken [µg/ml]

Amount found [µg/ml]

% Assay

CAR

17.5

17.57 ± 0.32

100.38 ± 1.84

PCM

32.5

32.53 ± 0.57

100.10 ± 1.75

CAF

3.2

3.23 ± 0.04

100.83 ± 1.10

Table 19: Summary and Conclusion of RP-HLPC method

Parameter

Limit

Result

Conclusion

 

CAR

PCM

CAF

Linearity and Range

R2 > 0.995

0.999

0.998

0.996

Method was Linear

Repeatability

RSD < 2

1.51-0.93

1.33-0.92

1.63-1.25

Method was -repeatable

LOD

-

0.246 µg/ml

0.501 µg/ml

0.06472 µg/ml

-

LOQ

-

0.746 µg/ml

1.521 µg/ml

0.196121 µg/ml

-

Intraday Precision

RSD < 2

1.52-0.92

1.32-0.95

1.61-1.26

Method was precise

Inter-day Precision

RSD < 2

1.46-0.88

1.28-0.87

1.52-1.18

Method was precise

% Recovery

98 – 102 %

99.71 -100.13

99.90 -100.82

99.79 -100.52

Method was accurate

Robustness

RSD < 2

1.48-1.37

1.16-1.04

1.66-1.26

Method was robust

Assay

98 – 102 %

100.38

100.10

100.83

-

Table 20: Forced degradation study

Types of stress conditions

% Degradation

CAR

PCM

CAF

Acid Hydrolysis

14.6 %

14 %

12.4 %

Base Hydrolysis

18.3 %

15.2 %

13.7 %

Oxidative Stress

14.5 %

18.3 %

17.1 %

Thermal Degradation

10.5 %

13.6 %

14.7%

CONCLUSION

The present method was proposed for the simultaneous determination of Carisoprodol, Paracetamol and Caffeine by using RP-HPLC is found to be simple, rapid, accurate and precise. The method was validated according to ICH guidelines. Degradation studies were carried out in acid, alkali, oxidative and dry heat stress condition. The results revealed that all drugs are stable in described condition. Therefore, the present method was found to be suitable for routine analysis of CAR, PCM and CAF in pharmaceutical dosage form.

ACKNOWLEDGEMENTS

The authors would like to thank, Yarrow chem Pvt. Ltd., RMS scientific services, for provided API, chemical and reagents for this research work. The successful completion of this research work was facilitated by the valuable guidance and facilities extended by the management of Smt. S.M. Shah Pharmacy College.

FINANCIAL SUPPORT

Despite the work being accomplished, funding details are undisclosed and, and no fund have been received.

CONFLICT OF INTEREST

The authors have explicitly stated that no financial or other conflicts of interest exist.

REFERENCES

  1. Indian Pharmacopoeia, Government of India, Ministry of Health and Family Welfare, Indian Pharmacopoeia Commission, Ghaziabad, Edition 8, 2018; 2,1492-1493.
  2. US pharmacopoeia 48 and national formulary 38, the United States pharmacopeial convention 2020;1,776-778.
  3. British Pharmacopoeia, British pharmacopoeia commission office, Medicine and healthcare products Regulatory Agency [MHRA], london, 2020; 1,442-443.
  4. Indian Pharmacopoeia, Government of India, Ministry of Health and Family Welfare, Indian Pharmacopoeia Commission, Ghaziabad, Edition 8, 2018; 3,2853-2854.
  5. British Pharmacopoeia, British pharmacopoeia commission office, Medicine and healthcare products Regulatory Agency [MHRA], london, 2020; 2,534-536.
  6. Indian Pharmacopoeia, Government of India, Ministry of Health and Family Welfare, Indian Pharmacopoeia Commission, Ghaziabad, Edition 8, 2018; 2,1445-1446.
  7. US pharmacopoeia 48 and national formulary 38, the United States pharmacopeial convention 2020; 1,645.
  8. British Pharmacopoeia, British pharmacopoeia commission office, Medicine and healthcare products Regulatory Agency [MHRA], london, 2020; 1,374-375.
  9. Murali D, Rambabu C. Stability indicating high performance liquid chromatographic method for the estimation of carisoprodol in bulk and in tablet dosage form. International Journal of PharmTech Research. 2016; 9(3): 171-180.
  10. Rao AL, Vijetha P. Development and Validation of Stability Indicating RP-HPLC Method for Simultaneous Estimation of Ibuprofen and Carisoprodol in Pharmaceutical Formulation. Open Journal of Analytical and Bioanalytical Chemistry. 2019; 3(1): 072-075.
  11. Khanage SG, Mohite PB, Dharam PG, Deshmukh VK. Development and Validation of Reversed Phase High Performance Liquid Chromatographic Method for Simultaneous Estimation of Paracetamol, Caffeine and Carisoprodol in Tablet Formulation. Eurasian Journal of Analytical Chemistry. 2015;10(3).
  12. Patel C, Prajapati L, Joshi A, Kharodiya M. Simultaneous Estimation of Ibuprofen and Carisoprodol in Synthetic Mixture by HPTLC Method. International Journal of Life Sciences and Review 2015; 1(11): 316-321.
  13. Rohith T, Ananda S, Netkal M, Made G. Method development and validation of Carisoprodol and its impurities by ultra violethigh perform--ance liquid chromatography, Adv. Anal. Chem. 2013; 3:15-19.
  14. Shantaram Gajanan K, Prachi Gangadhar D, Popat Baban M, Vinayak Kashinath D. UV-Spectrophotometric Method for the Simultaneous Estimation of Carisoprodol, Paracetamol and Caffeine: Validation and Application for Marketed Tablet Analysis. Iranian Journal of Analytical Chemistry. 2015; 2(2): 120-126.
  15. Sornchaithawatwong C, Vorrarat S, Nunthanavanit P. Simultaneous determination of paracetamol and its main degradation product in generic paracetamol tablets using reverse-phase HPLC. J Health Res. 2010; 24(3): 103-106.
  16. Sonone R, Tandel L, Jain V. Novel rapid isocratic RP-HPLC method for simultaneous estimation of phenylephrine hydrochloride, paracetamol, caffeine, diphenhydramine hydrochloride. Current Pharmaceutical Analysis. 2021; 17(6): 792-800.
  17. Pereira FJ, Rodríguez-Cordero A, López R, Robles LC, Aller AJ. Development and validation of an RP-HPLC-PDA method for determination of paracetamol, caffeine and tramadol hydrochloride in pharmaceutical formulations. Pharmaceuticals. 2021; 14(5):466.
  18. Dewani AP, Dabhade SM, Bakal RL, Gadewar CK, Chandewar AV, Patra S. Development and validation of a novel RP-HPLC method for simultaneous determination of paracetamol, phenylephrine hydrochloride, caffeine, cetirizine and nimesulide in tablet formulation. Arabian journal of chemistry. 2015; 8(4): 591-598.
  19. Acheampong A, Gyasi WO, Darko G, Apau J, Addai-Arhin S. Validated RP-HPLC method for simultaneous determination and quantification of chlorpheniramine maleate, paracetamol and caffeine in tablet formulation. Springerplus. 2016; 5: 1-8.
  20. Redasani VK, Gorle AP, Badhan RA, Jain PS, Surana SJ. Simultaneous determination of chlorpheniramine maleate, phenylephrine hydrochloride, paracetamol and caffeine in pharmaceutical preparation by RP-HPLC. Chemical Industry and Chemical Engineering Quarterly. 2013;19(1):57-65.
  21. Shah DA, Rana JP, Baldania SL, Chhalotiya UK, Bhatt KK. High-performance thin-layer chromatographic method for the estimation of Paracetamol, Dicyclomine Hydrochloride, and Mefenamic acid in combined tablet dosage form. JPC–Journal of Planar Chromatography–Modern TLC. 2014; 27: 52-57.
  22. Potawale RS, Gabhe SY. Simultaneous estimation of Tolperisone Hydrochloride and Paracetamol in combined tablet dosage form by validated normal phase HPTLC method. J Chem Pharm Res. 2013; 5: 532-537.
  23. Gaikwad SS, Kalkate SD, Bankar AA, Bansode AS. Quality by design optimization and validation of a HPTLC-MS method for simultaneous estimation of paracetamol and prochlorperazine from bulk and formulation. International Journal of Mass Spectrometry. 2024; 495: 117171.
  24. Aminu N, Chan SY, Khan NH, Farhan AB, Umar MN, Toh SM. A simple stability-indicating HPLC method for simultaneous analysis of paracetamol and caffeine and its application to determinations in fixed-dose combination tablet dosage form. Acta Chromatographica. 2019; 31(2): 85-91.
  25. Shantaram Gajanan K, Prachi Gangadhar D, Popat Baban M, Vinayak Kashinath D. UV-Spectrophotometric Method for the Simultaneous Estimation of Carisoprodol, Paracetamol and Caffeine: Validation and Application for Marketed Tablet Analysis. Iranian Journal of Analytical Chemistry. 2015; 2(2): 120-126.

Reference

  1. Indian Pharmacopoeia, Government of India, Ministry of Health and Family Welfare, Indian Pharmacopoeia Commission, Ghaziabad, Edition 8, 2018; 2,1492-1493.
  2. US pharmacopoeia 48 and national formulary 38, the United States pharmacopeial convention 2020;1,776-778.
  3. British Pharmacopoeia, British pharmacopoeia commission office, Medicine and healthcare products Regulatory Agency [MHRA], london, 2020; 1,442-443.
  4. Indian Pharmacopoeia, Government of India, Ministry of Health and Family Welfare, Indian Pharmacopoeia Commission, Ghaziabad, Edition 8, 2018; 3,2853-2854.
  5. British Pharmacopoeia, British pharmacopoeia commission office, Medicine and healthcare products Regulatory Agency [MHRA], london, 2020; 2,534-536.
  6. Indian Pharmacopoeia, Government of India, Ministry of Health and Family Welfare, Indian Pharmacopoeia Commission, Ghaziabad, Edition 8, 2018; 2,1445-1446.
  7. US pharmacopoeia 48 and national formulary 38, the United States pharmacopeial convention 2020; 1,645.
  8. British Pharmacopoeia, British pharmacopoeia commission office, Medicine and healthcare products Regulatory Agency [MHRA], london, 2020; 1,374-375.
  9. Murali D, Rambabu C. Stability indicating high performance liquid chromatographic method for the estimation of carisoprodol in bulk and in tablet dosage form. International Journal of PharmTech Research. 2016; 9(3): 171-180.
  10. Rao AL, Vijetha P. Development and Validation of Stability Indicating RP-HPLC Method for Simultaneous Estimation of Ibuprofen and Carisoprodol in Pharmaceutical Formulation. Open Journal of Analytical and Bioanalytical Chemistry. 2019; 3(1): 072-075.
  11. Khanage SG, Mohite PB, Dharam PG, Deshmukh VK. Development and Validation of Reversed Phase High Performance Liquid Chromatographic Method for Simultaneous Estimation of Paracetamol, Caffeine and Carisoprodol in Tablet Formulation. Eurasian Journal of Analytical Chemistry. 2015;10(3).
  12. Patel C, Prajapati L, Joshi A, Kharodiya M. Simultaneous Estimation of Ibuprofen and Carisoprodol in Synthetic Mixture by HPTLC Method. International Journal of Life Sciences and Review 2015; 1(11): 316-321.
  13. Rohith T, Ananda S, Netkal M, Made G. Method development and validation of Carisoprodol and its impurities by ultra violethigh perform--ance liquid chromatography, Adv. Anal. Chem. 2013; 3:15-19.
  14. Shantaram Gajanan K, Prachi Gangadhar D, Popat Baban M, Vinayak Kashinath D. UV-Spectrophotometric Method for the Simultaneous Estimation of Carisoprodol, Paracetamol and Caffeine: Validation and Application for Marketed Tablet Analysis. Iranian Journal of Analytical Chemistry. 2015; 2(2): 120-126.
  15. Sornchaithawatwong C, Vorrarat S, Nunthanavanit P. Simultaneous determination of paracetamol and its main degradation product in generic paracetamol tablets using reverse-phase HPLC. J Health Res. 2010; 24(3): 103-106.
  16. Sonone R, Tandel L, Jain V. Novel rapid isocratic RP-HPLC method for simultaneous estimation of phenylephrine hydrochloride, paracetamol, caffeine, diphenhydramine hydrochloride. Current Pharmaceutical Analysis. 2021; 17(6): 792-800.
  17. Pereira FJ, Rodríguez-Cordero A, López R, Robles LC, Aller AJ. Development and validation of an RP-HPLC-PDA method for determination of paracetamol, caffeine and tramadol hydrochloride in pharmaceutical formulations. Pharmaceuticals. 2021; 14(5):466.
  18. Dewani AP, Dabhade SM, Bakal RL, Gadewar CK, Chandewar AV, Patra S. Development and validation of a novel RP-HPLC method for simultaneous determination of paracetamol, phenylephrine hydrochloride, caffeine, cetirizine and nimesulide in tablet formulation. Arabian journal of chemistry. 2015; 8(4): 591-598.
  19. Acheampong A, Gyasi WO, Darko G, Apau J, Addai-Arhin S. Validated RP-HPLC method for simultaneous determination and quantification of chlorpheniramine maleate, paracetamol and caffeine in tablet formulation. Springerplus. 2016; 5: 1-8.
  20. Redasani VK, Gorle AP, Badhan RA, Jain PS, Surana SJ. Simultaneous determination of chlorpheniramine maleate, phenylephrine hydrochloride, paracetamol and caffeine in pharmaceutical preparation by RP-HPLC. Chemical Industry and Chemical Engineering Quarterly. 2013;19(1):57-65.
  21. Shah DA, Rana JP, Baldania SL, Chhalotiya UK, Bhatt KK. High-performance thin-layer chromatographic method for the estimation of Paracetamol, Dicyclomine Hydrochloride, and Mefenamic acid in combined tablet dosage form. JPC–Journal of Planar Chromatography–Modern TLC. 2014; 27: 52-57.
  22. Potawale RS, Gabhe SY. Simultaneous estimation of Tolperisone Hydrochloride and Paracetamol in combined tablet dosage form by validated normal phase HPTLC method. J Chem Pharm Res. 2013; 5: 532-537.
  23. Gaikwad SS, Kalkate SD, Bankar AA, Bansode AS. Quality by design optimization and validation of a HPTLC-MS method for simultaneous estimation of paracetamol and prochlorperazine from bulk and formulation. International Journal of Mass Spectrometry. 2024; 495: 117171.
  24. Aminu N, Chan SY, Khan NH, Farhan AB, Umar MN, Toh SM. A simple stability-indicating HPLC method for simultaneous analysis of paracetamol and caffeine and its application to determinations in fixed-dose combination tablet dosage form. Acta Chromatographica. 2019; 31(2): 85-91.
  25. Shantaram Gajanan K, Prachi Gangadhar D, Popat Baban M, Vinayak Kashinath D. UV-Spectrophotometric Method for the Simultaneous Estimation of Carisoprodol, Paracetamol and Caffeine: Validation and Application for Marketed Tablet Analysis. Iranian Journal of Analytical Chemistry. 2015; 2(2): 120-126.

Photo
Rashmi Shukla
Corresponding author

Smt. S.M. Shah Pharmacy College, Gujarat Technological University

Photo
Khushali Patel
Co-author

Smt. S.M. Shah Pharmacy College, Gujarat Technological University

Photo
Pinak Patel
Co-author

Smt. S.M. Shah Pharmacy College, Gujarat Technological University

Photo
Krunal Detholia
Co-author

Smt. S.M. Shah Pharmacy College, Gujarat Technological University

Photo
Sanjay Solanki
Co-author

Smt. S.M. Shah Pharmacy College, Gujarat Technological University

Rashmi Shukla, Khushali Patel, Pinak Patel, Krunal Detholia, Sanjay Solanki, Validated Stability-Indicating HPLC Method For Simultaneous Determination of Carisoprodol, Paracetamol, And Caffeine in A Combined Dosage Tablet, Int. J. of Pharm. Sci., 2025, Vol 3, Issue 6, 5517-5530. https://doi.org/10.5281/zenodo.15762813

More related articles
An Extensive Analysis of Achyranthes Aspera's (Ama...
Pratiksha Kardile, Amruta Varpe, Rohan Salve, Dipali Devkate, San...
Indian Pharmaceutical Regulatory Authority: Review...
Shashank Dattatray Dhole , R. B. Darade, ...
UV Spectrophotometric Method Development and Valid...
Dr. B. Satya Prasad, Dr. J. N. Suresh Kumar, G. Jaswanth, G. Eswa...
A Brief Review On – Role of Turmeric and Tulsi in Prevention and Treatment of ...
Utkarsh Mandage, Dr. Sarita Beldar, Indrayani Pagare, Samiksha Lokhande , Dr. Akshay Khade, ...
A Comprehensive Review of Breast Cancer: Classification, Stages, Risk Factors, A...
Chandraprabha Dewangan , Rajendra Kumar, Jyoti Prakash, Mayank Borkar, Ravind Kumar, ...
Related Articles
Nutritionally Enriched Gluten-Free Cookies...
Pooja Pisal, Shweta Khenat , Viraj Kurpad , Purva Kunjir, Shweta koulage, ...
Chemical Approaches to Bioemulsifiers...
Srushti Aoundhakar, Muskan Mujawar, Rajnanda Patil, Priyanka Mohite, Dr. D. R Jadge, ...
Advances In Gene Therapy for Fanconi Anemia Using Hematopoietic Stem Cells: Curr...
Subhashini.R, Tanuvarthini.S.B, Aishwarya.s, Hema.v, Priyadharshini.R, Sreelakshmi.S, ...
An Extensive Analysis of Achyranthes Aspera's (Amaranthaceae) Traditional Applic...
Pratiksha Kardile, Amruta Varpe, Rohan Salve, Dipali Devkate, Sanika Palange, Gayatri Khodade, Dr. R...
More related articles
An Extensive Analysis of Achyranthes Aspera's (Amaranthaceae) Traditional Applic...
Pratiksha Kardile, Amruta Varpe, Rohan Salve, Dipali Devkate, Sanika Palange, Gayatri Khodade, Dr. R...
Indian Pharmaceutical Regulatory Authority: Review...
Shashank Dattatray Dhole , R. B. Darade, ...
UV Spectrophotometric Method Development and Validation for the Estimation of Si...
Dr. B. Satya Prasad, Dr. J. N. Suresh Kumar, G. Jaswanth, G. Eswar, P. Nikhila, T. Uma, U. Dheeresh,...
An Extensive Analysis of Achyranthes Aspera's (Amaranthaceae) Traditional Applic...
Pratiksha Kardile, Amruta Varpe, Rohan Salve, Dipali Devkate, Sanika Palange, Gayatri Khodade, Dr. R...
Indian Pharmaceutical Regulatory Authority: Review...
Shashank Dattatray Dhole , R. B. Darade, ...
UV Spectrophotometric Method Development and Validation for the Estimation of Si...
Dr. B. Satya Prasad, Dr. J. N. Suresh Kumar, G. Jaswanth, G. Eswar, P. Nikhila, T. Uma, U. Dheeresh,...